| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 14 |
| 1 | METHOTREXATE | 13 |
| 2 | PEMBROLIZUMAB | 13 |
| 3 | PANITUMUMAB | 12 |
| 4 | LAMOTRIGINE | 10 |
| 5 | FLUOROURACIL | 8 |
| 6 | FLUOROURACIL CREAM, 0.5% | 8 |
| 7 | DEXAMETHASONE | 7 |
| 8 | DEXAMETHASONE 1.5 MG | 7 |
| 9 | OXALIPLATIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | WHITE PETROLATUM | 2 | 0.0014 |
| 1 | SODIUM HYALURONATE | 1 | 0.0012 |
| 2 | ERDAFITINIB | 1 | 0.0008 |
| 3 | AFATINIB | 5 | 0.0008 |
| 4 | PANITUMUMAB | 12 | 0.0007 |
| 5 | COBIMETINIB | 3 | 0.0007 |
| 6 | MECHLORETHAMINE HYDROCHLORIDE | 1 | 0.0004 |
| 7 | IMIQUIMOD | 1 | 0.0004 |
| 8 | CAPMATINIB | 1 | 0.0004 |
| 9 | ALBUMIN (HUMAN) | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 13 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 12 |
| 3 | Mood Stabilizer [EPC] | 12 |
| 4 | Platinum-based Drug [EPC] | 11 |
| 5 | Alkylating Drug [EPC] | 10 |
| 6 | Anti-epileptic Agent [EPC] | 10 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 9 | Kinase Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 12 | 0.0003 |
| 1 | Sigma-1 Agonist [EPC] | 2 | 0.0002 |
| 2 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Penem Antibacterial [EPC] | 4 | 0.0001 |
| 6 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Aluminum Complex [EPC] | 2 | 0.0001 |
| 8 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 9 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |